Elanco Animal Health (ELAN) Net Cash Flow (2017 - 2026)
Elanco Animal Health (ELAN) posted Net Cash Flow of -$112.0 million for Q1 2026, down 530.77% sequentially from $26.0 million in Q4 2025, and down 1020.0% YoY from $12.2 million in Q1 2025.
Elanco Animal Health (ELAN) Net Cash Flow (2017 - 2026) Analysis & Trends
Elanco Animal Health has reported Net Cash Flow for 10 years, with the latest figure at -$112.0 million in Q1 2026.
- Quarterly Net Cash Flow fell 1020.0% year-over-year to -$112.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$96.0 million (down 151.89% YoY) and the FY2025 annual result came in at $6.0 million, down 97.1% from the prior year.
- Net Cash Flow retreated to -$112.0 million in Q1 2026 per ELAN's latest filing, from $26.0 million in the prior quarter.
- Over five years, Net Cash Flow peaked at $179.0 million in Q2 2022 and troughed at -$291.0 million in Q1 2022.
- A 5-year average of -$9.2 million and a median of $5.0 million in 2023 frame the typical range for Net Cash Flow.
- The sharpest annual moves came in 2024 and 2026: Net Cash Flow jumped 1220.0% in 2024, then plunged 1020.0% in 2026.
- Over 5 years, Net Cash Flow stood at -$147.0 million in 2022, then jumped by 88.44% to -$17.0 million in 2023, then surged by 423.53% to $55.0 million in 2024, then plunged by 52.73% to $26.0 million in 2025, then slumped by 530.77% to -$112.0 million in 2026.
- According to Business Quant data, Net Cash Flow over the past three periods registered -$112.0 million, $26.0 million, and -$35.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | -81.00 Mn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | -458.00 Mn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -912.40 Mn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 93.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Alkermes | 8.15 Bn | 7.49 Bn | 397.90 Mn | 159.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 93.00 Mn |
| Jun 30, 2026 | 93.00 Mn |
| Mar 31, 2026 | -112.00 Mn |
| Mar 31, 2026 | -112.00 Mn |
| Dec 31, 2025 | 26.00 Mn |
| Dec 31, 2025 | 26.00 Mn |
| Sep 30, 2025 | -35.00 Mn |
| Sep 30, 2025 | -35.00 Mn |
| Jun 30, 2025 | 25.00 Mn |
| Jun 30, 2025 | 25.00 Mn |
| Mar 31, 2025 | -10.00 Mn |
| Mar 31, 2025 | -10.00 Mn |
| Dec 31, 2024 | 55.00 Mn |
| Dec 31, 2024 | 55.00 Mn |
| Sep 30, 2024 | 66.00 Mn |
| Sep 30, 2024 | 66.00 Mn |
| Jun 30, 2024 | 74.00 Mn |
| Jun 30, 2024 | 74.00 Mn |
| Mar 31, 2024 | 12.00 Mn |
| Mar 31, 2024 | 12.00 Mn |